Ras guanyl-releasing protein (RasGRP) (RasGRP)

Ras guanyl-releasing proteins (RasGRPs) are a family of four guanine nucleotide exchange factors (GEFs) that play a pivotal role in activating Ras and Rap small GTPases in response to intracellular signals. These proteins are characterized by a catalytic GEF domain and a regulatory region containing EF-hands for calcium binding and a C1 domain for diacylglycerol (DAG) binding (Stone, 2011 [1]). RasGRP1 is primarily expressed in T-cells and is essential for T-cell receptor signaling and thymocyte development; its dysregulation is frequently associated with T-cell acute lymphoblastic leukemia and systemic lupus erythematosus (Roose et al., 2007 [2]). RasGRP2, also known as CalDAG-GEFI, is a critical regulator of platelet aggregation and integrin activation, making it a potential target for anti-thrombotic therapies (Crittenden et al., 2004 [3]). RasGRP3 and RasGRP4 are involved in B-cell signaling and mast cell function, respectively, contributing to various inflammatory and allergic responses. Because RasGRPs are regulated by DAG, they are sensitive to pharmacological agents like bryostatin-1 and ingenol mebutate, which target C1 domains (Kedei et al., 2004 [4]). Therapeutic development focuses on achieving isoform-specific modulation to minimize off-target effects on other DAG-binding proteins like Protein Kinase C.

Other names

RasGRPCalcium and DAG-regulated guanine nucleotide exchange factorCalDAG-GEFRas guanyl-releasing protein 1Ras guanyl-releasing protein 2Ras guanyl-releasing protein 3Ras guanyl-releasing protein 4

Guanine nucleotide exchange factor (GEF) activity, specifically catalyzing the exchange of GDP for GTP on Ras and Rap small GTPases, thereby activating downstream MAPK/ERK and integrin signaling pathways (Stone, 2011 [1]).